mylan CEO over EPiPen price hikes Danielle Caputo PPPA 6017Afternoon The House Committee on Oversight and Government Reform held hearings to investigate the 500 price increase of EpiPens ID: 543922
Download Presentation The PPT/PDF document "Lawmakers grill" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Lawmakers grill mylan CEO over EPiPen price hikes
Danielle Caputo
PPPA 6017-AfternoonSlide2
The House Committee on Oversight and Government Reform held hearings to investigate the 500% price increase of
EpiPens that has occurred over the last decadeHead of
Mylan claims that they are not increasing the price to gain more revenue, but that their costs are so high that they only receive $274 from every $600 EpiPen they sell, and only $100 of that is profit.Slide3
Government Regulation Led to the Creation of a MonopolyRenewed patent protection
Strict FDA drug-approval processSlide4
Then Congress passed a law requiring schools to stock epinephrineSlide5
Now Congress wants to increase competition in the epinephrine marketConsidering easing government barriers to entry
Moving drugs more quickly through FDA approval process
Changing substitution laws to decrease product differentiation in the marketLooking into legality of contracts with schools